ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call

Rhea-AI Summary

ICU Medical (Nasdaq: ICUI) has announced its schedule for the fourth quarter 2024 earnings release and conference call. The company will release Q4 2024 results on Thursday, February 27, 2025, at approximately 4:00 p.m. ET (1:00 p.m. PT), followed by a conference call at 4:30 p.m. ET (1:30 p.m. PT) on the same day.

Investors can access the call via telephone at (800) 445-7795 using conference ID 'ICUMED'. Additionally, a webcast will be available through the Investors tab on ICU Medical's website at www.icumed.com, with replay options available.

News Market Reaction – ICUI

+1.16%

+1.16% Session move

In the trading session that priced this news, ICUI gained 1.16%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2024 earnings release and conference call.

The Company will release its fourth quarter 2024 results on Thursday, February 27, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, February 27, 2025. The call can be accessed at (800) 445-7795, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.

About ICU Medical

ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.

CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.

FAQ

When will ICU Medical (ICUI) release its Q4 2024 earnings?

ICU Medical will release its Q4 2024 earnings on Thursday, February 27, 2025, at approximately 4:00 p.m. ET (1:00 p.m. PT).

What time is ICU Medical's (ICUI) Q4 2024 earnings conference call?

ICU Medical's Q4 2024 earnings conference call is scheduled for Thursday, February 27, 2025, at 4:30 p.m. ET (1:30 p.m. PT).

How can investors access ICU Medical's (ICUI) Q4 2024 earnings call?

Investors can access the call by dialing (800) 445-7795 with conference ID 'ICUMED' or through the webcast available on ICU Medical's website under the Investors tab.

Will ICU Medical's (ICUI) Q4 2024 earnings call be available for replay?

Yes, the earnings call webcast will be available for replay through ICU Medical's website at www.icumed.com under the Investors tab.